SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Cencora, Inc. (New York Stock Exchange:COR)

US · Delayed Price · Currency is USD
323.32-1.37 (-0.42%)
 
Market Cap62.91B+9.1%
Revenue (ttm)332.77B+5.1%
Net Income2.62B+38.3%
EPS13.46+38.5%
Shares Out194.56M
PE Ratio23.91
Forward PE16.32
Dividend$2.40(0.74%)
Ex-Dividend DateAug 14, 2026
Volume1,040,979
Open322.24
Previous Close324.69
Day's Range321.92 - 326.96
52-Week Range244.82 - 377.54
Beta0.57
AnalystsBuy
Price Target358.14(+10.77%)
Earnings DateNov 4, 2026
-0.39% (1D)
No price history available.

About COR

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Address
1 West First Avenue, Conshohocken, PA, 19428-1800, US
Market Cap
62.91 billion
Employees
49,000
Industrial Classification
Medical - Distribution

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$3.98M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-0.42%
5 Days
-3.05%
1 Month
-0.52%
6 Months
-8.20%
1 Year
+9.11%

$COR stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of COR by members of U.S. Congress

PoliticianTypeTraded
Jared MoskowitzHouse / DSale$1.00K – $15.00KMay 5, 2026
Jared MoskowitzHouse / DPurchase$1.00K – $15.00KMar 30, 2026
Jared MoskowitzHouse / DPurchase$1.00K – $15.00KMar 22, 2026

Recently reported changes in COR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by COR's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q32025Q42026Q12026Q22026Q3

Source: SEC EDGAR (Form 4)

Corporate Lobbying

COR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

COR Revenue by Segment or Geography

COR's latest filing doesn't break out revenue by segment.

Source: SEC EDGAR (10-Q/10-K)

U.S. Patents

New COR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to COR from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in COR

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$1.83B
VOOVanguard S&P 500 ETF$1.59B
VOVanguard Morningstar Mid-Cap ETF$1.25B
IVViShares Core S&P 500 ETF$857.94M
SPYState Street SPDR S&P 500 ETF$776.43M
VTVVanguard Morningstar Value ETF$548.09M

Estimated from each fund’s disclosed top holdings × AUM

COR Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for COR is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from COR’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
2
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Company Directory & Stock Ticker Database | InsiderBuying.com